Page last updated: 2024-12-07
rb 7040
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 128739 |
| CHEMBL ID | 89126 |
| MeSH ID | M0142883 |
Synonyms (8)
| Synonym |
|---|
| CHEMBL89126 |
| rb 7040 |
| 1-(2-nitroimidazol-1-yl)-3-(2,2,3,3-tetramethylaziridin-1-yl)propan-2-ol |
| 1h-imidazole-1-ethanol, 2-nitro-alpha-((2,2,3,3-tetramethyl-1-aziridinyl)methy)- |
| rb-7040 |
| 105027-76-7 |
| 1-(2-nitro-1h-imidazol-1-yl)-3-(2,2,3,3-tetramethylaziridin-1-yl)propan-2-ol |
| DTXSID40909306 |
Research Excerpts
Dosage Studied
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.30
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 17.30 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.62 (4.65) | | Search Engine Demand Index | 13.88 (26.88) | | Search Engine Supply Index | 3.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |